Catalyst Health Ventures invests in disruptive solutions for unmet healthcare needs and is a Massachusetts-based venture capital firm.
Business Model:
Revenue: $0
Employees: 0-0
Address: 50 Braintree Hill Office Park
City: Braintree
State: MA
Zip: 02184
Country: US
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages both intellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2012 | BIOCIUS Life Sciences | Venture Round | - |
2/2022 | Epitel | Series A | 0 |
12/2013 | Maxwell Health | Series A | 6M |
1/2017 | Sera Prognostics | Series C | 22M |
7/2014 | SpaceOAR | Series D | 0 |
1/2015 | Sera Prognostics | Series B | 20M |
11/2014 | Sera Prognostics | Series B | 5M |
8/2011 | Lantos Technologies | Venture Round | 4.1M |
9/2010 | Lantos Technologies | Venture Round | 1.6M |
3/2016 | Maxwell Health | Series C | 0 |
3/2022 | Avive Solutions | Series A | 0 |
4/2015 | Saphena Medical | Series B | 1.8M |
12/2014 | Maxwell Health | Series B | 26.4M |
7/2011 | Allegro Diagnostics | Series A | 5.4M |
4/2020 | AtaCor Medical | Series B | 0 |
10/2020 | Instylla | Series B | 0 |
11/2011 | Sera Prognostics | Series A | 19.3M |
3/2010 | Vortex Medical | Series B | - |
3/2008 | Vortex Medical | Series A | 2.3M |
12/2018 | Conformal Medical | Series B | 9M |
10/2009 | SpaceOAR | Series B | 6.1M |
4/2013 | nVision Medical | Series A | 0 |
12/2014 | SevenOaks BioSystems | Series A | 1M |
9/2017 | Saphena Medical | Series C | 1.3M |
2/2020 | Aria CV | Series B | 0 |
7/2016 | SpaceOAR | Series E | 6M |
9/2013 | Cruzar Medsystems | Series A | 2.9M |
7/2015 | Aria CV | Series A | 7.8M |
1/2011 | SpaceOAR | Debt Financing | 3M |
3/2018 | Lantos Technologies | Venture Round | 0 |
5/2021 | PanTher Therapeutics | Series A | 5.4M |
6/2017 | Cruzar Medsystems | Series B | 2.3M |
12/2022 | Rejoni | Series B | 0 |
1/2011 | Sera Prognostics | Series A | 1.4M |
11/2010 | Sera Prognostics | Seed Round | - |
8/2020 | Conformal Medical | Series C | 85M |
12/2011 | nVision Medical | Seed Round | 125k |
7/2016 | nVision Medical | Series B | 12M |
3/2022 | Avive Solutions | Series A | 0 |
2/2022 | Epitel | Series A | 0 |
5/2021 | PanTher Therapeutics | Series A | 0 |
10/2020 | Instylla | Series B | 0 |
4/2020 | AtaCor Medical | Series B | 0 |
2/2020 | Aria CV | Series B | 0 |
12/2018 | Conformal Medical | Series B | 0 |
3/2018 | Lantos Technologies | Venture Round | 0 |
9/2017 | Saphena Medical | Series C | 0 |
6/2017 | Cruzar Medsystems | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|